DMD and Duchenne muscular dystrophy: Similar results were obtained in muscle cells isolated from a DMD patients characterized by a deletion of the dystrophin gene comprised between exons 45 and 50 treated with an AON designed to skip exon 51 of the dystrophin mRNA and capable of restoring the coding reading frame of the transcript, further supporting the clinical relevance of Dantrolene for the treatment of the disease.